Stay updated on Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Sign up to get notified when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.

Latest updates to the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated from v3.5.3 to v3.5.4, introducing a new revision tag for the page. This reflects a minor update to the page's metadata without altering the study details or visible content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check28 days agoChange DetectedThe page’s revision/build version indicator updated from v3.5.0 to v3.5.3 without changing any of the study details or content.SummaryDifference0.1%

- Check64 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0. No visible changes to study content or page layout.SummaryDifference0.1%

- Check78 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.4.2 updates the page framework without altering study data or critical details like eligibility or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check108 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed. This appears to be a minor page version update with no changes to study content or scheduling.SummaryDifference0.1%

Stay in the know with updates to Radical-Dose IGRT in Metastatic NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radical-Dose IGRT in Metastatic NSCLC Clinical Trial page.